Life Sciences Legislation and Regulation to Watch In 2015
Jan.02.2015 — Law360
John Fuson, a Washington, D.C.-based partner in Crowell & Moring's Advertising & Product Risk Management Group, discusses potential legislative changes in the life sciences sector in the upcoming year, including a possible repeal of the Affordable Care Act Medical Device Tax. Fuson also discusses the FDA's intent to regulate laboratory developed tests, noting, "This is a segment of the health care industry that has resisted oversight from the FDA. I'm sure that the agency is going to get a lot of feedback."